Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Net Cash Flow (2019 - 2025)

Historic Net Cash Flow for Sanofi (SNY) over the last 8 years, with Q4 2025 value amounting to -$9.2 billion.

  • Sanofi's Net Cash Flow rose 1298.98% to -$9.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 12571.73%. This contributed to the annual value of -$11.6 billion for FY2025, which is 88813.66% down from last year.
  • Sanofi's Net Cash Flow amounted to -$9.2 billion in Q4 2025, which was up 1298.98% from $1.6 billion recorded in Q3 2025.
  • Sanofi's Net Cash Flow's 5-year high stood at $11.3 billion during Q4 2021, with a 5-year trough of -$13.6 billion in Q4 2023.
  • Moreover, its 5-year median value for Net Cash Flow was $2.6 billion (2021), whereas its average is $1.4 billion.
  • In the last 5 years, Sanofi's Net Cash Flow surged by 944170022.64% in 2021 and then tumbled by 60500.42% in 2024.
  • Quarter analysis of 5 years shows Sanofi's Net Cash Flow stood at $11.3 billion in 2021, then decreased by 0.55% to $11.2 billion in 2022, then crashed by 221.46% to -$13.6 billion in 2023, then grew by 22.4% to -$10.6 billion in 2024, then grew by 12.99% to -$9.2 billion in 2025.
  • Its Net Cash Flow was -$9.2 billion in Q4 2025, compared to $1.6 billion in Q3 2025 and $7.9 billion in Q2 2025.